L. H. Patterson

1.1k total citations
31 papers, 925 citations indexed

About

L. H. Patterson is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, L. H. Patterson has authored 31 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Oncology. Recurrent topics in L. H. Patterson's work include Pharmacogenetics and Drug Metabolism (9 papers), Analytical Chemistry and Chromatography (4 papers) and Cancer therapeutics and mechanisms (4 papers). L. H. Patterson is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Analytical Chemistry and Chromatography (4 papers) and Cancer therapeutics and mechanisms (4 papers). L. H. Patterson collaborates with scholars based in United Kingdom, Czechia and United States. L. H. Patterson's co-authors include M.D. Burke, Helen M. Sheldrake, Peter C. Butler, Gerard A. Potter, Ketan C. Ruparelia, P. B. Farmer, Lesley A. Stanley, John H. Lamb, J. Jefferson P. Perry and Robert A. Falconer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

L. H. Patterson

31 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. H. Patterson United Kingdom 16 481 160 157 157 134 31 925
S. Gerhardt Germany 26 1.3k 2.8× 77 0.5× 299 1.9× 235 1.5× 76 0.6× 59 2.1k
Luigi Quintieri Italy 20 461 1.0× 73 0.5× 37 0.2× 262 1.7× 152 1.1× 53 1.0k
Yih Ho Taiwan 19 478 1.0× 65 0.4× 49 0.3× 144 0.9× 45 0.3× 55 951
Jeff Posakony United States 16 658 1.4× 59 0.4× 479 3.1× 197 1.3× 30 0.2× 25 1.5k
Joanne Brodfuehrer United States 14 347 0.7× 57 0.4× 24 0.2× 370 2.4× 113 0.8× 36 934
Robert M. Snapka United States 22 1.1k 2.3× 87 0.5× 87 0.6× 443 2.8× 51 0.4× 44 1.5k
Helena Almqvist Sweden 9 902 1.9× 88 0.6× 22 0.1× 225 1.4× 68 0.5× 12 1.3k
Katarzyna Lubecka Poland 14 769 1.6× 130 0.8× 65 0.4× 63 0.4× 16 0.1× 29 1.0k
James R. Gillig United States 7 532 1.1× 56 0.3× 62 0.4× 96 0.6× 17 0.1× 9 768
Philip Lecane United States 17 862 1.8× 238 1.5× 14 0.1× 297 1.9× 27 0.2× 22 1.5k

Countries citing papers authored by L. H. Patterson

Since Specialization
Citations

This map shows the geographic impact of L. H. Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. H. Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. H. Patterson more than expected).

Fields of papers citing papers by L. H. Patterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. H. Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. H. Patterson. The network helps show where L. H. Patterson may publish in the future.

Co-authorship network of co-authors of L. H. Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of L. H. Patterson. A scholar is included among the top collaborators of L. H. Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. H. Patterson. L. H. Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patterson, L. H., et al.. (2018). The role of integrins in acute leukemias and potential as targets for therapy. 1(3). 63–63. 3 indexed citations
2.
Vinader, V., et al.. (2013). Synthesis of a Pseudo-Disaccharide Library and Its Application to the Characterisation of the Heparanase Catalytic Site. PLoS ONE. 8(11). e82111–e82111. 14 indexed citations
3.
Falconer, Robert A., Rachel J. Errington, Steven D. Shnyder, Pamela J. Olúbùnmi Smith, & L. H. Patterson. (2012). Polysialyltransferase: A New Target in Metastatic Cancer. Current Cancer Drug Targets. 12(8). 925–939. 89 indexed citations
4.
Sheldrake, Helen M. & L. H. Patterson. (2009). Function and Antagonism of β Integrins in the Development of Cancer Therapy. Current Cancer Drug Targets. 9(4). 519–540. 66 indexed citations
5.
Steward, William P., Mark R. Middleton, Paul M. Loadman, et al.. (2007). The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study. Annals of Oncology. 18(6). 1098–1103. 34 indexed citations
6.
Yakkundi, Anita, Margaret Murray, Helen O. McCarthy, et al.. (2006). Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N. Cancer Gene Therapy. 13(6). 598–605. 36 indexed citations
7.
Lane, Catherine, William J. Griffiths, Barry Fuller, et al.. (2004). Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach. European Journal of Cancer. 40(14). 2127–2134. 25 indexed citations
8.
9.
Potter, Gerard A., L. H. Patterson, J. Jefferson P. Perry, et al.. (2002). The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. British Journal of Cancer. 86(5). 774–778. 316 indexed citations
10.
Loadman, Paul M., David J. Swaine, M.C. Bibby, Kevin J. Welham, & L. H. Patterson. (2001). A preclinical pharmacokinetic study of the bioreductive drug AQ4N.. PubMed. 29(4 Pt 1). 422–6. 16 indexed citations
11.
Swaine, David J., et al.. (2000). High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxide. Journal of Chromatography B Biomedical Sciences and Applications. 742(2). 239–245. 14 indexed citations
12.
13.
Richardson, Jonathan C. W., et al.. (1997). Rat renal cortical slices: Maintenance of viability and use in in vitro nephrotoxicity testing. Toxicology in Vitro. 11(5). 723–729. 2 indexed citations
14.
Brophy, Peter M., L. H. Patterson, Alan Brown, & David Pritchard. (1995). Glutathione S-transferase (GST) expression in the human hookworm Necator americanus: potential roles for excretory-secretory forms of GST. Acta Tropica. 59(3). 259–263. 41 indexed citations
15.
Brophy, Peter M., et al.. (1995). Secretory nematode SOD—Offensive or defensive?. International Journal for Parasitology. 25(7). 865–866. 19 indexed citations
16.
Fisher, Geoffrey R., Jeffrey Brown, & L. H. Patterson. (1990). Involvement of Hydroxyl Radical Formation and Dna Strand Breakage in the Cytotoxicity of Anthraquinone Antitumour Agents. Free Radical Research Communications. 11(1-3). 117–125. 29 indexed citations
17.
Fisher, Geoffrey R., Jeffrey Brown, & L. H. Patterson. (1989). Redox Cycling in MCF-7 Human Breast Cancer Cells by Antitumor Agents Based on Mitozantrone. Free Radical Research Communications. 7(3-6). 221–226. 12 indexed citations
18.
Patterson, L. H., et al.. (1986). In-vitro metabolism of lignocaine to its N-oxide. Journal of Pharmacy and Pharmacology. 38(4). 326–326. 5 indexed citations
19.
Brown, Joseph E., L. H. Patterson, J. Williamson, & Jeffrey Brown. (1982). Uptake, Elimination and Subcellular Distribution of Daunorubicin in Trypanosoma Rhodes Iense. Journal of Pharmacy and Pharmacology. 34(Supplement_12). 42P–42P. 3 indexed citations
20.
Glueckauf, E. & L. H. Patterson. (1974). The adsorption of some proteins on hydroxylapatite and other absorbents used for chromatographic separations. Biochimica et Biophysica Acta (BBA) - Protein Structure. 351(1). 57–76. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Gerhardt Breakdown of academic impact, for papers by Luigi Quintieri Breakdown of academic impact, for papers by Yih Ho Breakdown of academic impact, for papers by Jeff Posakony Breakdown of academic impact, for papers by Joanne Brodfuehrer Breakdown of academic impact, for papers by Robert M. Snapka Breakdown of academic impact, for papers by Helena Almqvist Breakdown of academic impact, for papers by Katarzyna Lubecka Breakdown of academic impact, for papers by James R. Gillig Breakdown of academic impact, for papers by Philip Lecane
Rankless by CCL
2026